(FN) Fabrinet - Overview
Exchange: NYSE •
Country: Cayman Islands •
Currency: USD •
Type: Common Stock •
ISIN: KYG3323L1005
Stock: Optical Switches, Transceivers, Lasers, Sensors, Optics
Total Rating 74
Risk 80
Buy Signal -0.11
| Risk 5d forecast | |
|---|---|
| Volatility | 78.3% |
| Relative Tail Risk | -4.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.81 |
| Alpha | 128.13 |
| Character TTM | |
|---|---|
| Beta | 2.608 |
| Beta Downside | 1.525 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.47% |
| CAGR/Max DD | 1.80 |
EPS (Earnings per Share)
Revenue
Description: FN Fabrinet February 26, 2026
Fabrinet (NYSE: FN) is a Cayman-incorporated provider of high-precision optical packaging and electro-mechanical manufacturing services, operating across North America, Europe, and the Asia-Pacific. The company’s capabilities span process design, supply-chain management, PCB assembly, integration, final testing, and advanced packaging for a broad portfolio that includes reconfigurable optical add-drop multiplexers, amplifiers, modulators, transceivers, tunable lasers, active optical cables, and a range of lasers and sensors for telecom, data-center, automotive, and medical markets.
In FY 2023 the firm generated $1.15 billion in revenue, a 13% year-over-year increase, and reported an operating margin of roughly 7%, supported by a growing backlog that now exceeds $1.6 billion. The surge in demand for 400 Gbps and higher-speed optical transceivers-driven by AI-fuelled data-center expansion and ongoing telecom capex-remains a key economic driver for Fabrinet’s growth trajectory.
For a deeper dive, see the ValueRay analysis of FN.
Headlines to watch out for
- Optical communications component demand drives revenue
- Industrial laser market growth impacts sales
- Supply chain efficiency affects manufacturing costs
- Datacenter interconnect demand boosts product sales
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 374.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -9.24 > 1.0 |
| NWC/Revenue: 44.63% < 20% (prev 49.18%; Δ -4.56% < -1%) |
| CFO/TA 0.09 > 3% & CFO 278.1m > Net Income 374.1m |
| Net Debt (-311.8m) to EBITDA (458.0m): -0.68 < 3 |
| Current Ratio: 2.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.2m) vs 12m ago -0.62% < -2% |
| Gross Margin: 12.01% > 18% (prev 0.12%; Δ 1.19k % > 0.5%) |
| Asset Turnover: 134.0% > 50% (prev 122.8%; Δ 11.15% > 0%) |
| Interest Coverage Ratio: -100.0k > 6 (EBITDA TTM 458.0m / Interest Expense TTM -1.0) |
Altman Z'' 8.95
| A: 0.53 (Total Current Assets 2.77b - Total Current Liabilities 1.04b) / Total Assets 3.27b |
| B: 0.70 (Retained Earnings 2.30b / Total Assets 3.27b) |
| C: 0.14 (EBIT TTM 400.7m / Avg Total Assets 2.91b) |
| D: 2.14 (Book Value of Equity 2.32b / Total Liabilities 1.08b) |
| Altman-Z'' Score: 8.95 = AAA |
Beneish M -2.41
| DSRI: 0.95 (Receivables 801.7m/680.1m, Revenue 3.89b/3.12b) |
| GMI: 1.02 (GM 12.01% / 12.27%) |
| AQI: 1.73 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 1.25 (Revenue 3.89b / 3.12b) |
| TATA: 0.03 (NI 374.1m - CFO 278.1m) / TA 3.27b) |
| Beneish M-Score: -2.41 (Cap -4..+1) = BBB |
What is the price of FN shares?
As of March 12, 2026, the stock is trading at USD 524.33 with a total of 437,226 shares traded.
Over the past week, the price has changed by -7.01%, over one month by +12.63%, over three months by -0.73% and over the past year by +165.08%.
Over the past week, the price has changed by -7.01%, over one month by +12.63%, over three months by -0.73% and over the past year by +165.08%.
Is FN a buy, sell or hold?
Fabrinet has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy FN.
- StrongBuy: 3
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 574.4 | 9.6% |
| Analysts Target Price | 574.4 | 9.6% |
FN Fundamental Data Overview March 10, 2026
P/E Trailing = 46.9655
P/S = 4.5043
P/B = 8.0249
P/EG = 1.19
Revenue TTM = 3.89b USD
EBIT TTM = 400.7m USD
EBITDA TTM = 458.0m USD
Long Term Debt = 4.88m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.69m USD (from shortTermDebt, last quarter)
Debt = 8.08m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -311.8m USD (from netDebt column, last quarter)
Enterprise Value = 17.53b USD (17.53b + Debt 8.08m - CCE 11.5m)
Interest Coverage Ratio = -400.7m (Ebit TTM 400.7m / Interest Expense TTM -1.0)
EV/FCF = 172.2x (Enterprise Value 17.53b / FCF TTM 101.8m)
FCF Yield = 0.58% (FCF TTM 101.8m / Enterprise Value 17.53b)
FCF Margin = 2.62% (FCF TTM 101.8m / Revenue TTM 3.89b)
Net Margin = 9.61% (Net Income TTM 374.1m / Revenue TTM 3.89b)
Gross Margin = 12.01% ((Revenue TTM 3.89b - Cost of Revenue TTM 3.42b) / Revenue TTM)
Gross Margin QoQ = 12.15% (prev 11.90%)
Tobins Q-Ratio = 5.36 (Enterprise Value 17.53b / Total Assets 3.27b)
Interest Expense / Debt = -0.00% (Interest Expense -1.0 / Debt 8.08m)
Taxrate = 5.93% (7.10m / 119.7m)
NOPAT = 376.9m (EBIT 400.7m * (1 - 5.93%))
Current Ratio = 2.68 (Total Current Assets 2.77b / Total Current Liabilities 1.04b)
Debt / Equity = 0.00 (Debt 8.08m / totalStockholderEquity, last quarter 2.18b)
Debt / EBITDA = -0.68 (Net Debt -311.8m / EBITDA 458.0m)
Debt / FCF = -3.06 (Net Debt -311.8m / FCF TTM 101.8m)
Total Stockholder Equity = 2.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.88% (Net Income 374.1m / Total Assets 3.27b)
RoE = 18.39% (Net Income TTM 374.1m / Total Stockholder Equity 2.03b)
RoCE = 19.65% (EBIT 400.7m / Capital Employed (Equity 2.03b + L.T.Debt 4.88m))
RoIC = 18.53% (NOPAT 376.9m / Invested Capital 2.03b)
WACC = 15.46% (E(17.53b)/V(17.54b) * Re(15.47%) + D(8.08m)/V(17.54b) * Rd(-0.00%) * (1-Tc(0.06)))
Discount Rate = 15.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.64%
[DCF] Terminal Value 60.70% ; FCFF base≈186.8m ; Y1≈230.4m ; Y5≈392.4m
[DCF] Fair Price = 80.71 (EV 2.58b - Net Debt -311.8m = Equity 2.89b / Shares 35.8m; r=15.46% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 93.72 | EPS CAGR: 23.99% | SUE: 0.70 | # QB: 0
Revenue Correlation: 96.83 | Revenue CAGR: 20.42% | SUE: 4.0 | # QB: 5
EPS current Year (2026-06-30): EPS=13.58 | Chg7d=+0.000 | Chg30d=+0.031 | Revisions Net=+7 | Growth EPS=+33.5% | Growth Revenue=+32.7%
EPS next Year (2027-06-30): EPS=16.29 | Chg7d=+0.444 | Chg30d=+0.753 | Revisions Net=+7 | Growth EPS=+20.0% | Growth Revenue=+18.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 13.3% (Discount Rate 15.5% - Earnings Yield 2.1%)
[Growth] Growth Spread = +4.6% (Analyst 18.0% - Implied 13.3%)
P/S = 4.5043
P/B = 8.0249
P/EG = 1.19
Revenue TTM = 3.89b USD
EBIT TTM = 400.7m USD
EBITDA TTM = 458.0m USD
Long Term Debt = 4.88m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.69m USD (from shortTermDebt, last quarter)
Debt = 8.08m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -311.8m USD (from netDebt column, last quarter)
Enterprise Value = 17.53b USD (17.53b + Debt 8.08m - CCE 11.5m)
Interest Coverage Ratio = -400.7m (Ebit TTM 400.7m / Interest Expense TTM -1.0)
EV/FCF = 172.2x (Enterprise Value 17.53b / FCF TTM 101.8m)
FCF Yield = 0.58% (FCF TTM 101.8m / Enterprise Value 17.53b)
FCF Margin = 2.62% (FCF TTM 101.8m / Revenue TTM 3.89b)
Net Margin = 9.61% (Net Income TTM 374.1m / Revenue TTM 3.89b)
Gross Margin = 12.01% ((Revenue TTM 3.89b - Cost of Revenue TTM 3.42b) / Revenue TTM)
Gross Margin QoQ = 12.15% (prev 11.90%)
Tobins Q-Ratio = 5.36 (Enterprise Value 17.53b / Total Assets 3.27b)
Interest Expense / Debt = -0.00% (Interest Expense -1.0 / Debt 8.08m)
Taxrate = 5.93% (7.10m / 119.7m)
NOPAT = 376.9m (EBIT 400.7m * (1 - 5.93%))
Current Ratio = 2.68 (Total Current Assets 2.77b / Total Current Liabilities 1.04b)
Debt / Equity = 0.00 (Debt 8.08m / totalStockholderEquity, last quarter 2.18b)
Debt / EBITDA = -0.68 (Net Debt -311.8m / EBITDA 458.0m)
Debt / FCF = -3.06 (Net Debt -311.8m / FCF TTM 101.8m)
Total Stockholder Equity = 2.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.88% (Net Income 374.1m / Total Assets 3.27b)
RoE = 18.39% (Net Income TTM 374.1m / Total Stockholder Equity 2.03b)
RoCE = 19.65% (EBIT 400.7m / Capital Employed (Equity 2.03b + L.T.Debt 4.88m))
RoIC = 18.53% (NOPAT 376.9m / Invested Capital 2.03b)
WACC = 15.46% (E(17.53b)/V(17.54b) * Re(15.47%) + D(8.08m)/V(17.54b) * Rd(-0.00%) * (1-Tc(0.06)))
Discount Rate = 15.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.64%
[DCF] Terminal Value 60.70% ; FCFF base≈186.8m ; Y1≈230.4m ; Y5≈392.4m
[DCF] Fair Price = 80.71 (EV 2.58b - Net Debt -311.8m = Equity 2.89b / Shares 35.8m; r=15.46% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 93.72 | EPS CAGR: 23.99% | SUE: 0.70 | # QB: 0
Revenue Correlation: 96.83 | Revenue CAGR: 20.42% | SUE: 4.0 | # QB: 5
EPS current Year (2026-06-30): EPS=13.58 | Chg7d=+0.000 | Chg30d=+0.031 | Revisions Net=+7 | Growth EPS=+33.5% | Growth Revenue=+32.7%
EPS next Year (2027-06-30): EPS=16.29 | Chg7d=+0.444 | Chg30d=+0.753 | Revisions Net=+7 | Growth EPS=+20.0% | Growth Revenue=+18.0%
[Analyst] Revisions Ratio: +1.00 (7 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 13.3% (Discount Rate 15.5% - Earnings Yield 2.1%)
[Growth] Growth Spread = +4.6% (Analyst 18.0% - Implied 13.3%)